Senores Pharmaceuticals Limited (SENORES) Share Price
NSE · Healthcare · Drug Manufacturers - General · ISIN INE0RB801010
Key metrics
- Market Cap
- ₹6,632 Cr
- P/E Ratio
- 50.69
- EPS
- 28.41
- Book Value
- 209.44
- P/B Ratio
- 6.88
- ROE
- 11.96%
- ROCE
- 10.49%
- Debt / Equity
- 0.35
- Net Margin
- 18.24%
- Revenue Growth
- 58.85%
- Profit Growth
- 97%
- Dividend Yield
- —
- 52W High
- ₹1,599.00
- 52W Low
- ₹662.45
- Market Cap Band
- mid cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics, as well as management and consultancy services. The company was incorporated in 2017 and is based in Ahmedabad, India.
- Headquarters
- Ahmedabad, India
- Promoter Holding
- 54.93%
The full Senores Pharmaceuticals Limited analysis
Create a free account to open the complete SENORES deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.